Dr Bernabeu will present the revolution of anti-mullerian hormone as a contraceptive and a means of delaying ovarian ageing at the Contraception Congress in Albacete

The Medical Director of Instituto Bernabeu, Dr Rafael Bernabeu, will participate in the 5^th edition of the Contraception Congress organised by the Castilla La Mancha Contraception Society due to be held in Albacete on the 10^th and 11^th November. The Director of the Instituto Bernabeu Group, Dr Rafael Bernabeu, will cover the revolutionary discovery of the uses of anti-mullerian hormone in his speech entitled 'A new paradigm in contraception: AMH and derivatives.'

The gynaecologist will expand upon ongoing clinical studies on the effect of anti-mullerian hormone that have given favourable results in initial tests. The gynaecologist will disclose information that is set to be a revolution in the field of contraception therapies and that also demonstrates that, by retaining ovarian reserve, there is an impact in terms of delaying ovarian ageing and the menopause.